Schrodinger Inc
Schrodinger is a technology company developing molecular modeling software for research in chemistry and biotechnology.
Price history of Schrodinger Inc
Price history of Schrodinger Inc
Performance & Momentum
Schrödinger Misses Q1 on Software Gains
Schrödinger reported a first quarter of 2026 marked by a larger-than-expected loss and slightly weaker-than-anticipated revenue, according to its latest results. Market reaction could remain cautious, with investors focusing on the group’s ability to turn its operational progress into a clear improvement in profitability. The company nevertheless highlighted the ramp-up of its cloud-based software licensing business, growth in ACV and new collaborations in drug discovery. These factors support the case for a medium-term turnaround, but they are still not enough to offset the negative impact of the quarterly shortfall.
Strategic Analysis
Schrodinger Inc • 2026
Schrödinger combines a high-margin scientific software business with an ambition in drug discovery, giving it a rare hybrid positioning in healthcare. Its advantage is built on molecular modeling and AI applied to chemistry, with a model that can serve both industrial clients and its own research pipeline.
- Differentiated positioning in molecular modeling, with recognized expertise in chemical and biotech research
- Hybrid model combining software revenues and potential value creation through drug discovery
- Exposure to a structural trend toward the digitalization of pharmaceutical research
- Dependence on the success of the biotech arm, which is riskier and more uncertain than the software business
- Very weak stock momentum, reflecting a loss of market confidence in the growth and profitability trajectory
Momentum is weak and clearly bearish, with a negative underlying trend across multiple time horizons, reflecting persistent pressure on the valuation. For an investor, this suggests a story with strong conceptual upside but still fragile from a stock market perspective, requiring tangible signs of execution and value creation before becoming attractive again.
Similar stocks to Schrodinger Inc
Recent News
Schrodinger Inc
Schrödinger Wins on Software Shift, AI Push
1 month agoSchrödinger is highlighting a new strategic phase centered on hosted software contracts and the use of AI to broaden its user base. The move is aimed at making revenues more recurring and more visible, a trend the market is welcoming in a rapidly evolving digital health sector. At the same time, several analysts have lowered their price targets, saying the shift to a hosted software model could weigh in the near term on revenue visibility and market sentiment. Even so, the company’s operational momentum and platform expansion remain supportive for SDGR over the medium term.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
